Activity
Every insider trade and institutional 13F change, ranked by impact. 181,316 moves.
| Date | Actor | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Frank Meghan CEO | Exercise | LULU Lululemon Athletica Inc Common Stock | $0 | +4K +12.18% | 34,570 0.03% of shares | low |
| Apr 21, 2026 | Holmes Audrey Dale Director | Grant | CFFI C & F Financial Corp Common Stock | $0 | +450 +3.26% | 14,235 0.44% of shares | low |
| Apr 1, 2026 | Baylouny John CEO | Exercise | DRS Leonardo DRS, Inc. Common Stock | $0 | +6K +3.86% | 161,616 0.06% of shares | low |
| Apr 1, 2026 | Baylouny John CEO | Exercise | DRS Leonardo DRS, Inc. Common Stock | $0 | +8K +5.51% | 159,363 0.06% of shares | low |
| Apr 1, 2026 | Baylouny John CEO | Exercise | DRS Leonardo DRS, Inc. Common Stock | $0 | +13K +8.76% | 156,733 0.06% of shares | low |
| Apr 1, 2026 | Baylouny John CEO | Grant | DRS Leonardo DRS, Inc. Common Stock | $0 | +27K +21.12% | 156,407 0.06% of shares | low |
| Apr 1, 2026 | Baylouny John CEO | Grant | DRS Leonardo DRS, Inc. Common Stock | $0 | +41K +38.38% | 146,688 0.05% of shares | low |
| Jun 2, 2026 | Ballotti Geoffrey A CEO | Gift | WH Wyndham Hotels & Resorts, Inc. Common Stock | $0 | -13K -2.27% | 546,395 0.74% of shares | low |
| Jun 10, 2026 | Hirawat Samit Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K | 6,405 0.02% of shares | low |
| Jun 10, 2026 | Christie Christopher Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K +38.46% | 23,059 0.06% of shares | low |
| Jun 10, 2026 | Young Alethia Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K +56.22% | 17,798 0.04% of shares | low |
| Jun 10, 2026 | Yang Michael J. Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K +47.82% | 19,798 0.05% of shares | low |
| Jun 10, 2026 | Bigal Marcelo Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K +56.22% | 17,798 0.04% of shares | low |
| Jun 10, 2026 | Froimson Mark Director | Grant | PCRX Pacira BioSciences Inc Common Stock | $0 | +6K +31.81% | 26,541 0.07% of shares | low |
| Jun 9, 2026 | Levy Anton J Director | Grant | WBD Warner Bros. Discovery, Inc. Series A Common Stock | $0 | +9K +0.96% | 958,067 0.04% of shares | low |
| May 5, 2026 | Bradway Robert A CEO | Grant | AMGN Amgen Inc Common Stock | $0 | +12K +2.44% | 508,941 0.09% of shares | low |
| May 4, 2026 | Griffin Jon Kevin Director | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +538 +0.75% | 72,161 0.08% of shares | low |
| May 4, 2026 | Lane Brian E. Director | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +538 +1.07% | 50,651 0.05% of shares | low |
| Apr 1, 2026 | Nelson Ryan Robert Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +14K +70.53% | 32,887 0.04% of shares | low |
| Apr 1, 2026 | McHugh Ryan Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +7K +54.76% | 20,501 0.02% of shares | low |
| Apr 1, 2026 | Morris Jesse E Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +54K +23.08% | 290,104 0.31% of shares | low |
| Apr 1, 2026 | Meserve Nicholas Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +22K +26.42% | 104,145 0.11% of shares | low |
| Apr 1, 2026 | Beauvais Jason B Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +34K +18.41% | 215,810 0.23% of shares | low |
| Apr 1, 2026 | Hyzak Dwayne L. CEO | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +82K +17.99% | 535,185 0.57% of shares | low |
| Apr 1, 2026 | Magdol David L. Executive | Grant | MAIN Main Street Capital CORP Common Stock | $0 | +59K +14.55% | 464,033 0.50% of shares | low |
| May 6, 2026 | Cancelmi Daniel J Director | Grant | ACHC Acadia Healthcare Company, Inc. Common Stock | $0 | +6K +95.56% | 12,956 0.01% of shares | low |
| May 15, 2026 | Burgdoerfer Stuart B Director | Exercise | ARHS Arhaus, Inc. Class A Common Stock | $0 | +832 +3.61% | 23,896 0.02% of shares | low |
| May 15, 2026 | Burgdoerfer Stuart B Director | Exercise | ARHS Arhaus, Inc. Class A Common Stock | $0 | +16K +231.67% | 23,064 0.02% of shares | low |
| May 8, 2026 | Burgdoerfer Stuart B Director | Grant | PGR Progressive CORP/OH/ Common | $0 | +1K +10.13% | 13,455 <0.01% of shares | low |
| May 27, 2026 | Herring Bradley Executive | Exercise | OPLN OPENLANE Inc Common Stock | $0 | +16K | 16,190 0.01% of shares | low |
| Jun 15, 2026 | Martin Brian Executive | Exercise | NTNX Nutanix, Inc. Class A Common Stock | $0 | +2K +13.76% | 15,727 <0.01% of shares | low |
| Jun 15, 2026 | Martin Brian Executive | Exercise | NTNX Nutanix, Inc. Class A Common Stock | $0 | +3K +25.68% | 13,825 <0.01% of shares | low |
| Jun 11, 2026 | Bluedorn Todd M Director | Grant | MDLN Medline Inc. Class A Common Stock | $0 | +5K +52.07% | 15,732 <0.01% of shares | low |
| Dec 16, 2025 | Bluedorn Todd M Director | Grant | MDLN Medline Inc. Class A Common Stock | $0 | +10K | 10,345 <0.01% of shares | low |
| Apr 27, 2026 | Weber Christophe Pierre CEO | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +165K +65.25% | 418,803 0.03% of shares | low |
| Apr 27, 2026 | Weber Christophe Pierre CEO | Grant | TAK Takeda Pharmaceutical Co Ltd Ordinary Shares | $0 | +79K +8.44% | 1,014,200 0.07% of shares | low |
| Apr 27, 2026 | Furuta Milano Executive | Grant | TAK Takeda Pharmaceutical Co Ltd Ordinary Shares | $0 | +8K +15.57% | 57,900 <0.01% of shares | low |
| Apr 27, 2026 | Plump Andrew Stewart Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +212K +35.76% | 806,572 0.05% of shares | low |
| Apr 27, 2026 | Ricci Gabriele Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +35K +28.19% | 159,126 0.01% of shares | low |
| Apr 27, 2026 | Bitetti Teresa Marie Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +65K +33.65% | 258,136 0.02% of shares | low |
| Apr 27, 2026 | Duprey Lauren Rusckowski Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +60K +35.60% | 228,503 0.01% of shares | low |
| Apr 27, 2026 | Kim Julie So-Young CEO | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +105K +32.46% | 430,145 0.03% of shares | low |
| Apr 27, 2026 | Platford Giles Richard Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +72K +32.02% | 297,363 0.02% of shares | low |
| Apr 27, 2026 | Pignagnoli Agosti Marcello Executive | Grant | TAK Takeda Pharmaceutical Co Ltd American Depositary Shares | $0 | +28K +19.18% | 172,348 0.01% of shares | low |
| May 26, 2026 | Smith Stephen M Director | Grant | CORZ Core Scientific, Inc./tx Common Stock | $0 | +19K | 18,961 <0.01% of shares | low |
| May 19, 2026 | Chin Moonhie Director | Grant | PRLB Proto Labs Inc Common Stock | $0 | +2K +11.00% | 22,306 0.09% of shares | low |
| May 22, 2026 | Paulson John Director | Grant | BHC Bausch Health Companies Inc. Common Shares, No Par Value | $0 | +46K +12.34% | 417,565 0.11% of shares | low |
| May 14, 2026 | Paulson John Director | Exercise | AAMI Acadian Asset Management Inc. Common Stock | $0 | +6K +24.20% | 29,510 0.08% of shares | low |
| May 14, 2026 | Caracciolo Kathleen M Director | Grant | FLL Full House Resorts Inc Common Stock | $0 | +25K +39.29% | 88,627 0.24% of shares | low |
| May 7, 2026 | Ostrover Douglas I CEO | Grant | OWL Blue Owl Capital Inc. Class C Shares | $0 | +789K +12.87% | 6,918,869 0.44% of shares | low |